Unifying Cell Therapy Logistics and Manufacturing
GE Healthcare Life Sciences |
Cell and gene therapies show promise as effective treatments, but there are some barriers to scaling them beyond the small numbers of patients they reach today. The supply chain and logistics for these advanced therapies are especially critical to ensure the right patient gets the right treatment at the right time. Collaboration is the key to solving challenges such as data management and process variability, as stakeholders work towards a common goal—getting these life-saving treatments to the people who need them.
Read the article to learn more about how a truly collaborative approach throughout the supply chain is needed to ensure patients receive your treatments.